The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass

Diabetes/Metabolism Research and Reviews

Volumn 28, Issue 5, 2012, Pages 439-446

  Kim, Mee Kyoung ^a   Lee, Hong Chan ^a   Lee, Seung Hwan ^a   Kwon, Hyuk Sang ^a   Baek, Ki Hyun ^a   Kim, Eung Kook ^a   Lee, Kwang Woo ^a   Song, Ki Ho ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Bariatric surgery; GLP 1; Remission of diabetes

Indexed keywords

C PEPTIDE; GLUCAGON LIKE PEPTIDE 1; HEMOGLOBIN A1C; PEPTIDE YY;

ADULT; ANALYTICAL PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; FEMALE; GLUCOSE TOLERANCE TEST; HORMONE RELEASE; HUMAN; INSULIN RESISTANCE; MALE; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REMISSION; ROUX Y ANASTOMOSIS; STOMACH BYPASS;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; OBESITY; PROGNOSIS; PROSPECTIVE STUDIES; REMISSION INDUCTION; YOUNG ADULT;

EID: 84863731694     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2297     Document Type: Article

References (29)

1. Vetter ML, Cardillo S, Rickels MR, Iqbal N. Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 2009; 150: 94-103.
2. Thaler JP, Cummings DE. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009; 150: 2518-2525.
3. Deitel M. Update: why diabetes does not resolve in some patients after bariatric surgery. Obes Surg 2011; 21: 794-796.
4. Bagger JI, Knop FK, Lund A, Vestergaard H, Holst JJ, Vilsbøll T. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab 2011; 96: 737-745.
5. Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia 2011; 54: 10-18.
6. Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab 2011; 96: E1372-E1379.
7. Perugini RA, Malkani S. Remission of type 2 diabetes mellitus following bariatric surgery: review of mechanisms and presentation of the concept of 'reversibility'. Curr Opin Endocrinol Diabetes Obes 2011; 18: 119-128.
8. Kim MK, Lee HC, Kwon HS, et al. Visceral obesity is a negative predictor of remission of diabetes 1year after bariatric surgery. Obesity (Silver Spring) 2011; 19: 1835-1859.
9. Lakdawala M, Bhasker A. Asian Consensus Meeting on Metabolic Surgery (ACMOMS). Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of bariatric and gastrointestinal metabolic surgery for treatment of obesity and type II diabetes mellitus in the Asian population: August 9th and 10th, 2008, Trivandrum, India. Obes Surg 2010; 20: 929-936.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
11. Kanat M, Winnier D, Norton L, et al. The relationship between β-cell function and glycated hemoglobin: results from the veterans administration genetic epidemiology study. Diabetes Care 2011; 34: 1006-1010.
12. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.
13. Miller MA. A calculated method for determination of IBW. Nutr Support Serv 1985; 5: 31-33.
14. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993; 17: 187-196.
15. Torquati A, Lutfi R, Abumrad N, Richards WO. Is Roux-en-Y gastric bypass surgery the most effective treatment for type 2 diabetes mellitus in morbidly obese patients? J Gastrointest Surg 2005; 9: 1112-1116.
16. Lee S, Yabe D, Nohtomi K, et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J 2010; 57: 119-126.
17. Kjems LL, Holst JJ, Vølund A, Madsbad S. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 2003; 52: 380-386.
18. Ahrén B. The dynamic incretin adaptation and type 2 diabetes. J Clin Endocrinol Metab 2011; 96: 620-622.
19. Camastra S, Manco M, Mari A, et al. Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss. Diabetes 2005; 54: 2382-2389.
20. Mari A, Manco M, Guidone C, et al. Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function. Diabetologia 2006; 49: 2136-2143.
21. Campos GM, Rabl C, Peeva S, et al. Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg 2010; 14: 15-23.
22. Bose M, Oliván B, Teixeira J, Pi-Sunyer FX, Laferrère B. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 2009; 19: 217-229.
23. Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism 2001; 50: 590-593.
24. Cho YM, Kieffer TJ. K-cells and glucose-dependent insulinotropic polypeptide in health and disease. Vitam Horm 2010; 84: 111-150.
25. Patriti A, Facchiano E, Sanna A, Gullà N, Donini A. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004; 14: 840-848.
26. Pournaras DJ, Aasheim ET, Søvik TT, et al. Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders. Br J Surg 2012; 99: 100-103.
27. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes 2006; 55: 2025-2031.
28. Mingrone G, Nolfe G, Gissey GC, et al. Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion. Diabetologia 2009; 52: 873-881.
29. Laferrère B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2008; 93: 2479-2485.